Evidence map›Paper›PMID 42695882›Full record

ArticleJournal of proteome research2026

Emerging Microbial Lipid Shifts in a Multistage Simulated Gut Inoculated with Human Fecal Microbiota.

Ifrat Tamanna, Katja Salonen, Helena Mannochio-Russo, Matilda Kråkström, Paulo Wender P Gomes, Vincent Charron-Lamoureux, Ipsita Mohanty, Sofia D Forssten, Arthur C Ouwehand, Tuulia Hyötyläinen and 4 more

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of proteome research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors.

Ifrat TamannaResearch Center for Infections and Immunity, Institute of Biomedicine, University of Turku and Turku University Hospital, 20520Turku, Finland.
Katja SalonenTurku Bioscience, University of Turku and Åbo Akademi University, 20520Turku, Finland.
Helena Mannochio-RussoCollaborative Mass Spectrometry Innovation Center, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California San Diego, La Jolla, California92093-065, United States.
Matilda KråkströmTurku Bioscience, University of Turku and Åbo Akademi University, 20520Turku, Finland.
Paulo Wender P GomesFaculty of Chemistry, Federal University of Pará, Belém, PA66075-110, Brazil.ORCID 0000-0001-5478-2448
Vincent Charron-LamoureuxCollaborative Mass Spectrometry Innovation Center, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California San Diego, La Jolla, California92093-065, United States.
Ipsita MohantyCollaborative Mass Spectrometry Innovation Center, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California San Diego, La Jolla, California92093-065, United States.ORCID 0000-0001-5311-6443
Sofia D ForsstenIFF Health Sciences, 02460Kantvik, Finland.
Arthur C OuwehandIFF Health Sciences, 02460Kantvik, Finland.
Tuulia HyötyläinenDepartment of Chemistry, Örebro University, 70281Örebro, Sweden.ORCID 0000-0002-1389-8302
Alex M DickensTurku Bioscience, University of Turku and Åbo Akademi University, 20520Turku, Finland.ORCID 0000-0002-3178-8449
Pieter C DorresteinCollaborative Mass Spectrometry Innovation Center, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California San Diego, La Jolla, California92093-065, United States.ORCID 0000-0002-3003-1030
Matej OrešičTurku Bioscience, University of Turku and Åbo Akademi University, 20520Turku, Finland.
Santosh LamichhaneResearch Center for Infections and Immunity, Institute of Biomedicine, University of Turku and Turku University Hospital, 20520Turku, Finland.ORCID 0000-0002-9292-3595

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Food residues that bypass human digestion are further digested by gut microbes, leading to the production of diverse metabolites, including lipids. To investigate how lipids in our intestine are affected during this transition, we used a colon simulator with four distinct vessels (V1-V4) that mimic the proximal to distal part of the human colon. In total, 44 samples were collected from the colon simulator vessels (V1-V4). We observed dynamic shifts in a diverse array of microbially linked lipid molecules in the simulated intestinal chyme, including bile acids and N-acyl amides with short- and odd-chain lipids. Histamine-linked N-acyl lipids (histamine-C5) increased from the proximal to the distal colon vessels (pH 5.5-7.0), whereas putrescine-linked ones (putrescine-C19:2), initially abundant in the media, decreased across the colon vessels. We uncovered dynamic associations between in vitro-derived short-chain N-acyl lipids (C4:0, C5, C6, and C7 conjugates) and major lipid species such as cholesterol esters, phosphatidylethanolamines, ceramides, and sphingomyelins. To determine the broader relevance of these findings, we applied a reverse metabolomics approach and examined N-acyl lipid profiles in human small intestine and fecal samples from public data sets. Our results validate the colon simulator as a dynamic model for studying microbially transformed metabolites and suggest its potential utility as a platform for discovering novel microbial metabolites with relevance to human and animal health.

Indexed as

ColonFecesGastrointestinal MicrobiomeLipid MetabolismLipidsBile Acids and SaltsHistamineHumansPutrescineBile Acids and SaltsHistamineLipidsPutrescinegut microbiomelipidsmetabolomicsmicrobial metaboliteN-acyl lipids

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.